수술 중 신경 모니터링(IONM) 시장 : 제품 및 서비스별, 소스 유형별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global intraoperative neuromonitoring (IONM) market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.88% during 2025-2033.

An intraoperative neuromonitoring (IONM) system comprises a group of procedures that can detect, monitor, and confirm nerve function and help minimize the odds of neurological problems during or after neurological surgical procedures. It reduces the risks of nerve function being damaged as a result of improper positioning of the patient or any neurophysiologically-relevant nerve structures. An IONM allows surgeons to identify electrophysiologic changes during spine, head or neck surgery, which may be crucial in extending incisions, placing implants, positioning limbs, and performing retraction techniques that can prevent permanent nerve damage. Using targeted neurostimulation, nerve structures can be identified to prevent potential damage, thus allowing surgeons to focus on optimizing interventions while preserving function. Consequently, these systems are extensively used in neuro, ENT, emergency, visceral, cardiothoracic, orthopedic, and vascular surgeries.

Intraoperative Neuromonitoring (IONM) Market Trends:

The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson's disease and Alzheimer's disease. In addition to this, the escalating demand for minimally invasive and non-invasive surgeries resulting in a higher uptake of advanced intraoperative neuromonitoring devices is propelling the market. Moreover, the growing trend of medical tourism across the globe is also creating lucrative growth opportunities for the market. The market is further driven by the expanding expenditure on advanced healthcare services. Some of the other factors providing an impetus to the market include the paradigm shift towards outsourced monitoring, the increasing geriatric population that is susceptible to developing neurological disorders, favorable government initiatives and reimbursement plans, and extensive research and development (R&D), collaborations, and joint ventures among the key players.

Key Market Segmentation:

Breakup by Product and Services:

• Systems
• Accessories
• Services

Breakup by Source Type:

• Insourced Monitoring
• Outsourced Monitoring

Breakup by Application:

• Spinal Surgery
• Neurosurgery
• Vascular Surgery
• ENT Surgery
• Orthopedic Surgery
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed.

Key Questions Answered in This Report

• 1.What was the size of the global Intraoperative Neuromonitoring (IONM) market in 2024?
• 2.What is the expected growth rate of the global Intraoperative Neuromonitoring (IONM) market during 2025-2033?
• 3.What are the key factors driving the global Intraoperative Neuromonitoring (IONM) market?
• 4.What has been the impact of COVID-19 on the global Intraoperative Neuromonitoring (IONM) market?
• 5.What is the breakup of the global Intraoperative Neuromonitoring (IONM) market based on the source type?
• 6.What is the breakup of the global Intraoperative Neuromonitoring (IONM) market based on application?
• 7.What are the key regions in the global Intraoperative Neuromonitoring (IONM) market?
• 8.Who are the key players/companies in the global Intraoperative Neuromonitoring (IONM) market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intraoperative Neuromonitoring (IONM) Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product and Services

• 6.1 Systems
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Source Type

• 7.1 Insourced Monitoring
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Outsourced Monitoring
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Spinal Surgery
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Neurosurgery
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Vascular Surgery
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 ENT Surgery
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Orthopedic Surgery
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers (ASCs)
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Accurate Monitoring LLC
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Computational Diagnostics Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 inomed Medizintechnik GmbH
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Intranerve LLC
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Medtronic plc
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Natus Medical Incorporated
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 NeuroMonitoring Technologies Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Neurophysiology Services Asia
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Nihon Kohden Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 NuVasive Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Specialtycare Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Technomed
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio